Abzu

Abzu

One-liner: Abzu develops trustworthy and explainable AI solutions for the pharmaceutical R&D sector.

Company slogan: Abzu is the best in class in silico disease understanding and drug design company.

Positioning: “Abzu is positioned as a provider of trustworthy and explainable AI specifically tailored for the pharmaceutical R&D sector, emphasizing its unique capabilities in data analysis and insights generation.”

Description: “Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D.

Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.”

Employees: 27

Website: Visit website

Headquarters: “Nordhavn, Capital Region”

Ownership: Privately Held

Founded: 2018

Company type: AI company

Use cases: “pharma R&D, drug design, understanding disease, RNA therapeutics”

Pricing:

Client sector: pharmaceutical industry

Business model: subscription

Products: QLattice

Is API available: no

Website title: “Abzu: Trustworthy, explainable AI for pharma R&D.”

Website description: “Abzu’s AI is built for the modern researcher, where explainability, small data, and new insights are at the core of innovative discoveries.”

Linkedin: https://www.linkedin.com/company/abzu/

Youtube: https://www.youtube.com/@abzu_ai

Instagram: https://www.instagram.com/abzu_ai/

Facebook:

Twitter: https://twitter.com/AbzuAI

Crunchbase: https://www.crunchbase.com/organization/abzu

Email: